Please login to the form below

Not currently logged in
Email:
Password:

Kate Aldous joins Lansons as an associate director

She joins its healthcare team from Red Door Unlimited

Lansons Kate AldousUK-based communications consultancy Lansons has appointed Kate Aldous as an associate director in its healthcare team.

Aldous brings 11 years of health communications experience to the team, joining from Red Door Unlimited where she also served as an associate director.

During this time, Aldous was responsible for leading ethical and consumer healthcare campaigns for clients including Astellas, AstraZeneca, Eli Lilly, Novartis and Sanofi.

Prior to Red Door Unlimited she worked at Huntsworth Health, and was promoted from account executive to account manager in 2007.

Scott McKenzie, joint managing director and head of change and employee engagement at Lansons, said: “We've brought Kate into Larsons to help service the growing demand we're seeing in the healthcare space.

“We're doing a lot more work across the sector, but in particular projects based around business transformation, corporate reputation, innovation and brand.

“Kate is a wonderful consultant and her experience will be incredibly valuable as we continue to build our presence in a sector that faces many reputational and business challenges.”

24th May 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics